JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molnar, L. R.
Right arrow Articles by Taylor, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molnar, L. R.
Right arrow Articles by Taylor, D. A.

Vol. 295, Issue 3, 1258-1266, December 2000


Alterations in Neuronal gamma -Aminobutyric AcidA Receptor Responsiveness in Genetic Models of Seizure Susceptibility with Different Expression Patterns1

Lance R. Molnar2, William W. Fleming and David A. Taylor

Department of Pharmacology and Toxicology, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, Morgantown, West Virginia

    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The genetically epilepsy-prone rat (GEPR) is a unique animal model of seizure predisposition with substrains (i.e., GEPR-NE, GEPR-3, and GEPR-9) that exhibit different seizure patterns in response to the same stimulus. Among many deficits identified in these animals, reduced responses to GABAA receptor agonists have been described in several brain regions of the GEPR-9. However, few studies have quantitatively analyzed this difference in responsiveness or have examined and compared the responsiveness of GEPR-3 neurons with the other strains. Using intracellular recording, we determined and compared the responsiveness of Purkinje neurons from GEPR-3 animals with those of control (both Sprague-Dawley and GEPR-NE) and GEPR-9 rats at different developmental ages. In GEPR-9 animals, the EC50 value for GABA and muscimol was shifted 3-fold to the right, with no reduction in maximum. In contrast, GEPR-3 animals showed a significant reduction in the maximum hyperpolarizing response to only GABA and muscimol with no change in the EC50 values. Responsiveness to glutamate, aspartate, norepinephrine, and diazepam was unchanged in both strains, indicating that the change in responsiveness was highly selective for GABAA receptor agonists. Changes in responsiveness in animals <15 days of age suggests that deficits in GABAergic function exist before the development of seizure susceptibility. In addition, the data are the first to reveal that the GEPR-3 and GEPR-9 exhibit different changes in GABAA receptor function and may provide significant insight into the cellular mechanism underlying differences between these two strains.

    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Seizure disorders are a heterogeneous group of syndromes characterized by recurrent synchronous neuronal hyperexcitability, inappropriately altering responsiveness to a variety of stimuli. Proposed mechanisms underlying this hyperexcitability are based on the premise that a shift occurs in the excitatory/inhibitory balance of neurotransmission in the brain toward elevated excitation (Meldrum, 1990; Tasker and Dudek, 1991; Olsen et al., 1999). The cellular modification(s) responsible for this shift could be either altered sensitivity to excitatory and/or inhibitory neurotransmitter(s), alteration in the release and/or metabolism of neurotransmitter(s), or some combination of these effects. A variety of animal models with enhanced propensity toward seizure generation exist, including several genetic models (for review, see Jobe et al., 1991).

The genetically epilepsy-prone rat (GEPR) inherits the propensity for seizures as a polygenetic and autosomal trait (Ribak et al., 1988). Other than a convulsive predisposition, the GEPRs exhibit no gross evidence of any other neurological dysfunctions (Jobe et al., 1993a,b). Three strains of the GEPR rats, each expressing different seizure patterns after audiogenic stimulation, have been characterized (Reigel et al., 1986; Dailey et al., 1989; Jobe et al., 1991). These are the GEPR-9, GEPR-3, and GEPR-NE (nonepileptic) strains, the latter serving as the genetic control strain. The GEPR-9 exhibits full tonic clonic seizures when presented with audiogenic stimuli, whereas the GEPR-3 exhibits only clonic seizures after an identical stimulus (Dailey et al., 1989). In addition to sensitivity to audiogenic stimuli, the animals develop spontaneous seizures (Jobe et al., 1986; Dailey et al., 1989) and exhibit heightened responsiveness to other convulsive stimuli such as kindling (Savage et al., 1986), electroshock, or pentylenetetrazol (Browning et al., 1990).

Deficits in a number of neurotransmitter systems have been identified in the GEPRs (Jobe et al., 1991). One abnormality that has been identified in the GEPR, an alteration in the function of the inhibitory neurotransmitter gamma -aminobutyric acid (GABA), is of particular interest because it appears to be shared with a number of other animal models of seizure disorders (DeDyn et al., 1990; Houser, 1991; Jobe et al., 1991; Gale, 1992; Snodgrass, 1992). A decrease in neuronal responsiveness to GABAergic agents has been described in the inferior colliculus (Faingold et al., 1986a,b), cerebral cortex (Waterhouse, 1986), hippocampus (Evans et al., 1994; Vermu-Ahuja et al., 1998), and cerebellum (Gould et al., 1991, 1995) of the GEPR-9. Other alterations in GABAergic function have been identified, including both reductions in GABA levels in several brain areas (Lasley, 1991) and changes in the GABAA receptor population ranging from an increase in the cerebral cortex (Booker et al., 1986) to no change in the cerebellum (Gould et al., 1995). Changes in GABAergic function have been investigated far less in the GEPR-3 than in the GEPR-9 and not at all from an electrophysiological standpoint. Therefore, examination of GABA responsiveness in these two strains would provide valuable new information.

GEPR animals do not exhibit seizure predisposition before postnatal day 15 (Jobe et al., 1991). Examining neuronal responsiveness at different ages during development offers two advantages: 1) animals <15 days of age would have no prior seizure history, thereby ensuring that alterations in neuronal responsiveness were innate differences rather than consequences of prior seizure activity; and 2) sensitivity of seizure-prone animals can be compared with both controls and animals of the same strain that had not yet developed the propensity for seizures. Most of the electrophysiological studies to date have been conducted in adult animals. Verma-Ahuja et al. (1998) have reported increased excitability in hippocampal CA3 neurons of young (i.e., <15-day-old) GEPR-9 animals that was due, at least in part, to reduced GABAergic inhibition.

The present study quantitatively examines the basic electrophysiological properties and sensitivity characteristics of Purkinje neurons in cerebellar slices of GEPR-NE, GEPR-3, GEPR-9, and control Sprague-Dawley rats. The cerebellum was chosen to study based upon existing data from this laboratory describing changes in GABA responsiveness (Gould et al., 1991, 1995) and the well documented changes that occur during development of the cerebellum. The results of these studies will provide the first set of data quantitatively comparing the responsiveness of any GEPR-3 neuronal population to that of both strains of control animals and the GEPR-9. In addition, the ability to compare the electrical and pharmacological properties of these neurons at different developmental ages provides an opportunity to correlate any changes in cellular responsiveness with seizure predisposition.

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Animals. GEPR-NE, GEPR-3, and GEPR-9 animals were purchased from the colonies maintained at the University of Illinois at Peoria. The GEPR strain was derived from Sprague-Dawley stock by selective breeding for audiogenic seizure susceptibility (Laird and Jobe, 1987). Therefore, Sprague-Dawley animals purchased from Harlan Sprague-Dawley (Indianapolis, IN) were used as an additional control group. Most animals used in these studies were received as part of a mother and litter shipment because a significant component of the study was developmental and there was a need to make certain that the animals were age-matched. The animals were housed in plastic cages to reduce the possibility of seizure production resulting from normal care as the animals age. Care was taken in the selection of animals for specific experiments to ensure that neurons included for analysis were obtained from different preparations taken from animals from different litters to reduce the bias provided by multiple neuron recording from either a single animal or within a single litter. All procedures involving animals were conducted according to protocols approved by the Institutional Animal Care and Use Committee.

Brain Slices. Cerebellar slices were prepared from animals of the various strains according to the methods described by Llinas and Sugimori (1980a,b), Crepel et al. (1981), Dupont et al. (1987), and Kano and Konnerth (1992) with some modifications as described by Molnar et al. (1999). Briefly, animals were anesthetized with CO2 and subsequently decapitated with a guillotine. After decapitation, the skull and dura mater overlying the cerebellum were removed, the cerebellar peduncles were severed using a sterile scalpel, and the cerebellum removed. Immediately upon removal, the cerebellum was placed into aerated (95% O2, 5% CO2) artificial cerebrospinal fluid (aCSF) kept on ice at approximately 4°C. Artificial cerebrospinal fluid contained 126 mM NaCl, 5 mM KCl, 1.3 mM MgSO4, 1.2 mM NaH2PO4, 26 mM NaHCO3, 2.4 mM CaCl2, and 10 mM glucose. The cerebellum, still in iced aCSF, was then blocked by sagittal cuts at each vermian vein and one of the cut ends glued to a Teflon chuck using cyanoacrylate adhesive. The cerebellum was supported on the chuck by a notched agar block previously prepared and glued to the chuck. Agar cutting blocks were prepared by pouring molten agar (5% by weight in 150 mM NaCl) into 10-ml plastic syringes cut off at one end, cooled, and then cut to an appropriate size as needed. Using a Vibroslice oscillating tissue slicer (World Precision Instruments, Sarasota, FL), 300-µm-thick sagittal sections of the cerebellar vermis were cut while maintained in aerated, 4°C aCSF. Upon obtaining each slice, it was immediately transferred, using a wide mouthed, fire-polished glass pipette, to a plastic-mesh basket submerged in a plastic beaker containing continuously aerated aCSF and kept on ice. All slices used were cut and transferred to the incubation beaker within 10 min after decapitation. The incubation beaker was kept on ice until 15 min postdecapitation, and then removed from ice and allowed to slowly (over a 2-h period) warm to room temperature (20-22°C) before initial recordings.

Electrophysiological Recording. After the recovery period, slices were individually transferred to a holding apparatus. The holding apparatus with the brain slice was then placed in a 1.5-ml laminar flow recording chamber continuously superfused with aerated aCSF maintained at 22-25°C. Temperature was continuously monitored using a Yellow Springs Instruments thermistor probe placed in the recording chamber. Perfusion of aCSF was maintained at 3 ml/min via a pressure-assisted gravity feed system. The slice was then viewed under a dissecting microscope (Nikon SMZ-2T) using a Dolan-Jenner Fiber-Lite fiber optic light source and a bipolar stimulating electrode (Teflon-coated platinum wire) for antidromic identification of neurons was placed on the white matter.

Standard intracellular recording was performed using single-barreled borosilicate glass microelectrodes filled with 3 M potassium acetate with resistances of 80 to 110 MOmega . The electrical activity and cellular currents generated were then amplified and monitored under the bridge recording configuration using an AXOCLAMP-2A amplifier (Axon Instruments, Foster City, CA). Electrophysiological signals were monitored on an oscilloscope (Tektronix 5110, 5111A) and led to a computer after A/D conversion through a TL-1 DMA interface (Axon Instruments) for data acquisition, real time analysis, and/or storage for subsequent off-line analysis using Axotape 2.0 (Axon Instruments).

Cells at least 50 µm, but no greater than 250 µm, from the surface of the slice were impaled with the assistance of a Narishige hydraulic micromanipulator and were identified as Purkinje neurons based upon the antidromic invasion of the soma after electrical stimulation of the axon (white matter). Criteria for inclusion of a given neuron in the population for statistical analysis included the establishment of a stable resting membrane potential (RMP) between -35 and -75 mV and the production of an antidromic action potential after white matter stimulation. Cellular input resistance (IR) was determined by regularly (2-5-s intervals) passing several steps of depolarizing and hyperpolarizing currents through the recording electrode. The voltage change induced by each electrotonic potential was later quantified to assess input resistance based upon Ohm's law. The duration of the electrotonic potential used was individualized for each neuron so that the membrane capacitance was fully charged for that neuron (typically 150-250 ms).

Drug Application. Exposure of neurons to drugs was accomplished through the addition of known concentrations of drug to the superfusing solution. Dead time for drug application was less than 5 s. Muscimol, GABA, glutamate, aspartate, diazepam, norepinephrine, bicuculline, and baclofen were prepared as stock solutions in advance in aCSF and stored at -20°C. Aliquots were thawed and diluted to final concentrations in fresh, aerated aCSF just before use. When multiple drugs were applied to a single neuron, the effects of prior drug applications were allowed to completely wash out before subsequent exposure to another agent. This was noted by a complete return of the membrane potential back to RMP. For determining changes in IR during drug applications, IR was compared before and during drug application by injecting current at a regular interval during the recording of RMP. The IR was calculated from a series of randomly selected electrotonic potential injections (10 before drug application while at RMP, 10 at steady-state maximal effect of drug) and then averaged before comparison. When bicuculline (a GABAA-selective antagonist) was applied to a slice, no subsequent recordings of responses to any agonist other than GABA or muscimol were made from that slice to avoid residual effects upon other neurons in the same slice. Thus, statistical analysis of the impact of bicuculline on GABA and muscimol responses could be made with a paired analysis. Furthermore, concentration-response curves were made by applying single increasing concentrations of drug (about 1 min/concentration) while allowing time for complete washout of effect between concentrations (noted by a return to RMP), which varied with the drug used.

For concentration-response curves, the membrane response (hyperpolarization for GABA and muscimol, depolarization for glutamate and aspartate) was normalized to the maximum response obtained in Sprague-Dawley Purkinje neurons, such that differences in maximal responses would still be evident by examining the concentration-response curve. Curves were fit by nonlinear regression analysis using SigmaPlot software (SPSS, Inc., Chicago, IL), and the subsequent best fit estimations of EC50 values are reported as geometric mean values according to Fleming et al. (1972). When investigating the effect of modulators of the GABAA receptor, norepinephrine (500 µM) or diazepam (100 µM) was superfused for 1 min and the effects on membrane potential were measured. After a 5-min recovery period, the appropriate estimated EC50 concentration of GABA was superfused for 1 min and the effects on membrane potential were determined. After another 5-min recovery period, the combination of GABA and modulator (norepinephrine or diazepam) was superfused for 1 min and the subsequent membrane polarization effects quantified.

Statistical Analysis of Data. Two similar methods were used for statistical analysis of collected data. For parameters that were assessed across time (i.e., versus age), an ANOVA using a nested design was performed to test for the effect of age. Multiple comparisons were then made using orthogonal contrast and the alpha -values were adjusted via the method of Bonferroni. Because 10 multiple comparisons were made in each instance where this method was used, a significant P value was <= .005 for these comparisons. For comparing the effects of drugs between strains, an analysis of variance with nested design was also used. However, in these instances no multiple comparisons were performed, thus a significant P value was <= .05 for these comparisons. Care was taken in the planning of experiments to ensure that neurons included in any given population for statistical analysis included neurons recorded from at least three different slice preparations taken from animals that came from different litters to avoid litter and multiple neuron bias in the analysis.

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Basic Electrical Membrane Properties. The RMP and IR of Purkinje neurons were measured using intracellular recording in cerebellar slices from control (Sprague-Dawley and GEPR-NE) and seizure prone (GEPR-3 and GEPR-9) animals. These electrical membrane properties were compared not only between animal strains but also with respect to animal age. To provide reasonable sample sizes for valid comparisons between animal strains, the data were grouped in 5-day periods beginning with postnatal day 10 (P10) and including an adult group that consisted of animals 30 days postnatal or older (P30+). This grouping method also provided an age group consisting purely of animals with no prior seizure history (P10-14). Table 1 presents the data from these experiments.


                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
Influence of age on electrical properties of Purkinje neurons of Sprague-Dawley, GEPR-NE, GEPR-3, and GEPR-9 rats

RMP (mV) and IR (MOmega ) of Purkinje neurons in cerebellar slices from Sprague-Dawley, GEPR-NE, GEPR-3, and GEPR-9 rats at various postnatal ages (days). Data presented are the mean ± S.E.M. Numbers in parentheses indicate the number of cells used to calculate mean values. No group was composed of cells obtained from less than three different animals from three different litters. The same cells were used to measure both RMP and IR, and thus sample sizes are identical for equivalent groups.

As indicated in Table 1, there were no statistically significant differences in RMP or IR between any of the animal strains for a given age period (P > .05). However, there were significant differences in both RMP and IR for each animal strain with respect to age (P < .005 by multiple comparisons). This is consistent with the observation of Molnar et al. (1999) of a significant hyperpolarization of Sprague-Dawley Purkinje neurons through an increase in sodium pump sites that was due to an increase in the alpha 3 subunit isoform (Biser et al., 2000) over the same time period. The membrane became more hyperpolarized and the membrane IR decreased with increasing animal age with the majority of the change occurring between the P10-14- and P15-19-aged animals (Table 1). As such, the RMP and IR measured from P10-14 animals of each strain were significantly depolarized from all other age groups (P < .005 by multiple comparisons).

Intracellular Comparison of Purkinje Neuron Response to Drug Superfusion. The membrane responses to various drugs and neurotransmitters were measured using intracellular recording techniques and exposure to single concentrations of drug. The effects of the GABA receptor agonists (muscimol, GABA, and baclofen), the GABAA receptor antagonist bicuculline, and the excitatory agonists glutamate and aspartate on membrane polarization are presented in Table 2 for P10-14 and P15+ animals. Animals 15 days or older were placed into a single group because there were no differences among the 5-day age subgroups during that period. Both GABA (10 µM) and the GABAA-selective agonist muscimol (1 µM) induced prominent hyperpolarizations of Sprague-Dawley and GEPR-NE Purkinje neuron membranes, which were not statistically different between the control animals for either age group (P > .05). However, the response of Purkinje neurons to both 1 µM muscimol and 10 µM GABA from the GEPR-3 and GEPR-9 rats displayed a significantly reduced hyperpolarization, irrespective of age (P < .05; Table 2). In addition, the magnitude of the hyperpolarizaton to both agonists was significantly less in the GEPR-9 compared with the GEPR-3 (Table 2). There were no differences within animal groups with respect to age (P > .05).


                              
View this table:
[in this window]
[in a new window]
 
TABLE 2
Drug-induced changes in Purkinje neuron membrane polarization (mV) of Sprague-Dawley (S-D), GEPR-NE, GEPR-3, and GEPR-9 rats

Changes in membrane potential (mV) of Purkinje neurons in slices from Sprague-Dawley, GEPR-NE, GEPR-3, and GEPR-9 rats induced by application of a single concentration of drug during intracellular recording. Mean responses are reported in mV ± S.E.M. Numbers in parentheses represent the number of cells in the recording population from no less than three different preparations each from different litters. For both muscimol and GABA, only hyperpolarizing responses were used to calculate the mean response. All drug concentrations were 10 µM except for muscimol (1 µM) and bicuculline (30 µM).

The mean effects for GABA and muscimol on the membrane potential presented in Table 2 reflect only the hyperpolarizing responses that were obtained. An unexpected outcome of these experiments was the appearance of occasional depolarizing effects of these agonists when applied to Purkinje neurons only from animals less than 15 days of age. These depolarizations were variable in amplitude and were observed in six Sprague-Dawley, three GEPR-NE, one GEPR-3, and six GEPR-9 Purkinje neurons. The relative occurrence (21% of Sprague-Dawley, 23% of GEPR-NE, 7% in GEPR-3, and 31% of GEPR-9 Purkinje neurons) and variable magnitude of these depolarizations between animal strains suggested that they constituted a minor response of the neurons studied and, therefore, were not investigated further.

The effects of both agonists were blocked by concomitant administration of bicuculline (30 µM; a GABAA receptor-selective antagonist), indicating that GABA and muscimol were exerting their effects via GABAA receptor activation (Table 2). Bicuculline (30 µM) was without significant effect on membrane polarization when superfused alone (Table 2), indicating that there was little if any endogenous GABAA receptor activation in these preparations. Baclofen (10 µM), a GABAB-selective agonist, had minimal effects on Purkinje neurons from any of the animal strains. Although modest in magnitude, these effects were qualitatively and statistically significantly different for both the GEPR-3 and GEPR-9 animals in both age groups compared with similarly aged Sprague-Dawley and GEPR-NE animals (P < .05). Baclofen was observed to induce a small hyperpolarization in Sprague-Dawley and GEPR-NE Purkinje neurons and a slight net depolarization in GEPR-3 and GEPR-9 Purkinje neurons (Table 2) in both age groups.

Table 2 also presents the mean membrane depolarizing effects of the excitatory neurotransmitters glutamate and aspartate at a concentration of 10 µM, in animals from both age groups. As with the GABA receptor ligands, there were no significant differences between the two control animal strains for either age group (P > .05). However, as illustrated in Table 2, Purkinje neurons from younger animals responded differently from those of the older animals in both rat strains. In the case of both aspartate and glutamate, there was a slight but significant increase in the depolarizing effect of these agonists in the older animals (P < .005 by multiple comparisons). In contrast to the findings with GABA and muscimol, both GEPR-3 and GEPR-9 Purkinje neurons had statistically equivalent responses to both aspartate and glutamate compared with either Sprague-Dawley or GEPR-NE Purkinje neurons (P > .05). Similar to the two control animal groups, Purkinje neurons from both seizure-prone GEPR strains also displayed a statistically significant increase in the depolarizing effects of these agonists with age (P < .005 by multiple comparisons).

The next step in comparing Purkinje neuron responsiveness among these strains of animals was to perform concentration-response curves to a variety of different agonists. Concentration-response curves were constructed on neurons from animals 15 days and older (P15+) by superfusing single, increasing concentrations of drug while allowing recovery of RMP to baseline between applications as described under Materials and Methods. The response to each of these agonists was relatively rapid and, thus, drug application time was typically 1 min or less for a given concentration of agonist. Full concentration-response curves to GABA, muscimol, glutamate, and aspartate are depicted in Figs. 1 to 4, respectively.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   A, GABA concentration-response curves for Sprague-Dawley, GEPR-NE, and GEPR-9 Purkinje neurons. Values are plotted as a percentage of the maximal hyperpolarization obtained in Sprague-Dawley Purkinje neurons. Values represent mean responses with error bars indicating S.E.M. There were no statistical differences in maximal effect (P > .05), but the estimated geometric mean EC50 value for GABA in GEPR-9 Purkinje neurons was significantly elevated 3-fold (P < .05). B, mean concentration-response curves of Purkinje neurons to superfusion of GABA in Sprague-Dawley (from Fig. 1A) and GEPR-3 animals. Responses are normalized as a percentage of the maximal response obtained in Sprague-Dawley neurons and are presented as the mean with error bars representing the S.E.M. The responses of GEPR-3 Purkinje neurons to concentrations of GABA of 10 µM and above were significantly (P < .05) reduced compared with those from Sprague-Dawley animals without a change in the geometric mean EC50 values, suggesting a reduction in maximum response.

Figure 1 shows the concentration-response curves generated from the superfusion of GABA at various concentrations (0.1-300 µM). Maximal hyperpolarizing responses, of approximately 15 mV in magnitude, were observed in neurons from Sprague-Dawley, GEPR-NE, and GEPR-9 rats. Although the magnitude of the maximal responses to GABA was not significantly different between GEPR-9 and control Purkinje neurons, there was a distinct shift to the right of the concentration-response curve (Fig. 1A). In contrast to data obtained with GEPR-9 animals, the concentration-response curve obtained from Purkinje neurons of GEPR-3 animals displayed a significant decrease in maximum response (P < .05), but no rightward displacement of the curve (Fig. 1B).

Similar results were obtained when concentration-response curves for muscimol were constructed (Fig. 2, A and B). The concentration-response curves for both Sprague-Dawley and GEPR-NE animals were nearly identical and maximal hyperpolarizations of approximately 15 mV in magnitude were achieved in both strains. Even though GEPR-9 Purkinje neurons exhibited statistically equivalent maximal hyperpolarizations compared with control animals (P > .05), there was a significant rightward shift of the muscimol concentration-response curve for GEPR-9 neurons (Fig. 2A) that appeared comparable to the shift in the concentration-response curve to GABA (Fig. 1A). Similar results to those found with GABA were obtained when concentration-response curves for muscimol were constructed in GEPR-3 neurons (Fig. 2B). The mean curve for muscimol in the GEPR-3 neurons was not significantly shifted relative to Sprague-Dawley neurons, but the maximum response was significantly depressed (P < .05; Fig. 2B).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2.   A, muscimol concentration-response curves for Sprague-Dawley, GEPR-NE, and GEPR-9 Purkinje neurons. Values are plotted as a percentage of the maximal hyperpolarization obtained in Sprague-Dawley Purkinje neurons. Values represent mean responses with error bars indicating S.E.M. There were no statistical differences in maximal effect (P > .05), but the estimated geometric mean EC50 value for GEPR-9 Purkinje neurons was significantly shifted 3-fold to the right of those for Sprague-Dawley and GEPR-NE Purkinje neurons (P < .05). B, mean concentration-response curves of Purkinje neurons from Sprague-Dawley (from Fig. 2A) and GEPR-3 animals to superfusion of muscimol. Responses are normalized as a percentage of the maximal response obtained in Sprague-Dawley neurons and presented as the mean with error bars representing the S.E.M. The responses of GEPR-3 Purkinje neurons to muscimol at concentrations of 1 µM and higher were significantly (P < .05) reduced compared with those from Sprague-Dawley neurons but the geometric mean EC50 values were not significantly different.

Concentration-response curves for the excitatory neurotransmitters glutamate and aspartate are depicted in Figs. 3 and 4, respectively. Similar to the results obtained with single concentrations of these agonists, no differences were found between animal strains. Maximal depolarizations of 17 to 18 mV to each agonist (with glutamate inducing maximal depolarizations at slightly lower concentrations) were evident for Purkinje neurons from each animal type.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   A, glutamate concentration-response curves for Sprague-Dawley, GEPR-NE, and GEPR-9 Purkinje neurons. Values are plotted as a percentage of the maximal depolarization obtained in Sprague-Dawley Purkinje neurons. Values represent mean responses with error bars indicating S.E.M. There were no statistical differences in maximal effect or the estimated geometric mean EC50 values between animal strains (P > .05). B, mean concentration-response curves of Purkinje neurons from Sprague-Dawley (from Fig. 3A) and GEPR-3 animals to superfusion of glutamate. Responses are normalized as a percentage of the maximum response obtained in Sprague-Dawley neurons. There were no significant differences in the concentration-response curves obtained from neurons of the GEPR-3 compared with those of the Sprague-Dawley.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4.   A, aspartate concentration-response curves for Sprague-Dawley, GEPR-NE, and GEPR-9 Purkinje neurons. Values are plotted as a percentage of the maximal depolarization obtained in Sprague-Dawley Purkinje neurons. Values represent mean responses with error bars indicating S.E.M. There were no statistical differences in maximal effect or the estimated geometric mean EC50 values between animal strains (P > .05). B, mean concentration-response curves of Purkinje neurons in Sprague-Dawley (from Fig. 4A) and GEPR-3 animals to superfusion of aspartate. Responses are normalized as a percentage of the maximum response obtained in Sprague-Dawley neurons. There were no significant differences in the concentration-response curves obtained from neurons of the GEPR-3 compared with those of the Sprague-Dawley.

The contrast between GEPR-3, Sprague-Dawley, and GEPR-9 Purkinje neurons is most clearly evident through comparisons of the geometric mean EC50 values (Table 3). There is no significant difference in EC50 values for either GABA or muscimol between Purkinje neurons from Sprague-Dawley, GEPR-NE, and GEPR-3 rats (Table 3). However, for both GABA and muscimol, the EC50 value is significantly higher (P < .05) in neurons from GEPR-9 animals (3.1- and 3.2-fold, respectively) in comparison to values from either the Sprague-Dawley or GEPR-NE controls or the GEPR-3 animals. Table 3 also illustrates that there were no differences in the calculated mean EC50 values for either glutamate or aspartate between Purkinje neurons of Sprague-Dawley, GEPR-NE, GEPR-3, or GEPR-9 rats. Thus, the selective reduction in responsiveness to GABAA receptor activation is expressed differently between the two seizure-prone strains.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 3
Geometric mean EC50 values (µM) for various agonists in Purkinje neurons from Sprague-Dawley, GEPR-NE, GEPR-3, and GEPR-9 rats

Geometric mean EC50 values ± S.E.M. (in µM) determined from concentration-response curves for membrane polarization induced by various agonists in Purkinje neurons. Numbers in parentheses indicates the number of cells. Italicized numbers indicate relative magnitude of geometric mean values compared to Sprague-Dawley control animals as an indicator of the shift in the concentration-response curve (e.g., a value of 1 = no shift).

In an attempt to further elucidate the possible mechanism of this apparent selective subsensitivity of GEPR-9 Purkinje neurons to GABAA receptor activation, the next set of experiments surveyed the effects of two modulators of the GABAA receptor-mediated responses, norepinephrine and diazepam, on Purkinje neurons from P15+ aged animals. These studies compared only the GEPR-9 with the two control strains to determine whether modulation of GABA action could account for the rightward shift of the concentration-response curve. To conduct these experiments, GABA concentrations near the calculated EC50 value (Table 3) for each animal strain studied (and thus equieffective) were chosen. As can be seen in Table 4, when given alone both norepinephrine and diazepam induced only small hyperpolarizations in Purkinje neurons from each animal strain studied. However, the magnitude of these membrane potential changes was not significantly different between animal strains (P > .05). Importantly, the concentrations of GABA chosen (7 µM for the Sprague-Dawley and GEPR-NE and 20 µM for the GEPR-9) produced statistically equivalent membrane hyperpolarizations of about half-maximal responses as those observed in the full concentration-response curves. When combinations of either GABA + norepinephrine or GABA + diazepam were applied, potentiated hyperpolarizations of comparable magnitude were observed for Purkinje neurons from each animal strain. Furthermore, the differences in the magnitude of the combination drug treatment and the GABA only exposure were not statistically different between animal strains (P > .05). Thus, the selective subsensitivity of GEPR-9 Purkinje neurons appears to occur only to direct activators of the GABAA receptor.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 4
Influence of modulators of GABA function on membrane responses (mV) of Purkinje neurons from Sprague-Dawley, GEPR-NE, and GEPR-9 rats to GABA

Changes in membrane potential (mV) of Purkinje neurons in cerebellar slices from Sprague-Dawley, GEPR-NE, and GEPR-9 rats induced by GABA, norepinephrine, and diazepam alone and in combination using intracellular recording techniques.

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

To study the mechanisms that underlie the development of the neuronal hyperexcitability that characterizes seizure predisposition, many investigators have chosen to examine genetic animal models of epilepsy because many of these models share important traits with human forms of epilepsy (Jobe et al., 1991). In the present studies, Purkinje neurons of the cerebellum of different strains of GEPRs were investigated electrophysiologically in an attempt to identify a general mechanism that may account for the seizure susceptibility and differences in seizure pattern that exist in this animal model. The cerebellum was chosen because of the previous semiquantitative studies from this laboratory that identified a change in responsiveness of Purkinje neurons to GABA and muscimol (Gould et al., 1991, 1995) and the well understood processes of development of this brain region. The present experiments were also undertaken to determine whether GABA responsiveness is changed in GEPR-3 Purkinje neurons and, if so, how the change compared with that observed in the GEPR-9. The studies were designed to provide a quantitative assessment of the magnitude and specificity of changes in sensitivity of GEPR-9 and GEPR-3 neurons compared with both the Sprague-Dawley and GEPR-NE control strains at ages before and after the animals developed seizure susceptibility.

The first goal was to compare the basic membrane properties of Purkinje neurons between GEPR and control animals both before and after seizure susceptibility develops. These studies indicated that the membrane properties among animal strains were equivalent for every age group tested (Table 1). The RMP values reported here are consistent with other reports for both young (Molnar et al., 1999) and adult animals (Puia et al., 1994; Molnar et al., 1999). The cellular IR observed was also similar to previously published values for Purkinje neurons (Crepel and Delhaye-Bouchaud, 1979; Molnar et al., 1999). Thus, these experiments indicate that any differences in agonist sensitivity are unlikely to be the result of a general change in the excitability of Purkinje neurons.

The next objective was to compare the membrane-polarizing effects of single concentrations of various drugs and neurotransmitters on Purkinje neurons from Sprague-Dawley, GEPR-NE, GEPR-3, and GEPR-9 rats. The results indicated a specific reduction in responsiveness to GABAA receptor activation in both groups of seizure-prone animals (Table 2). Purkinje neurons from GEPR-9 animals of both age groups were much less responsiveness to the hyperpolarizing effects of both muscimol (1 µM) and GABA (10 µM) compared with control animals. The GEPR-3 animals (Table 2) also showed a significantly reduced response to GABAA receptor activation that was intermediate in magnitude between the control and the GEPR-9 responses. Neurons of both young (<P15) and adult (>= P15) GEPR-3 animals exhibited the same magnitude of reduction in maximum response to the hyperpolarizing effects of both muscimol (1 µM) and GABA (10 µM). The existence of this reduced response in GEPR-3 and GEPR-9 animals <15 days of age suggests that the deficit exists before seizure susceptibility and extends the studies of Verma-Ahuja et al. (1998) in hippocampal CA3 neurons to include the cerebellar Purkinje neuron. The lack of seizure susceptibility in animals with reduced responsiveness does not rule out the possibility that the GABAergic deficit is the underlying cause of seizure susceptibility because the neuronal connectivity required for the spread of depolarizing activity may simply not be present at this age.

The effects of both muscimol and GABA were due to GABAA receptor activation because bicuculline, a GABAA receptor-selective antagonist, fully blocked the effects of both GABA and muscimol when applied concomitantly (Table 2). In addition, baclofen, a GABAB receptor-selective agonist, was without significant effect on neurons in these control preparations similar to previous studies in Purkinje neurons (Parfitt et al., 1990; Cheun and Yeh, 1992; Gould et al., 1995), indicating that there was very little, if any, GABAB receptor activity. Thus, these studies confirm the observation that the primary effects of GABA on Purkinje neurons of the rat cerebellum are mediated via the GABAA receptor. It is interesting that both GEPR-3 and GEPR-9 neurons showed statistically significant but small modifications in response to baclofen. The switch to depolarizing responses to baclofen is a curious finding that remains unexplained. It is also not well defined how significant this magnitude of change in membrane polarization will be to the operation of the cell.

The next step was to more thoroughly investigate the responsiveness of Purkinje neurons by comparing complete concentration-response curves. The curves constructed to GABA, muscimol, glutamate, and aspartate for control GEPR-NE and Sprague-Dawley animals (Figs. 1-4, respectively) demonstrate that the responsiveness of Purkinje neurons from these two animal strains is similar. No significant differences were found in either the maximum responses or EC50 values (Table 3) for any of the agonists in these control strains. However, comparing GEPR-3 and GEPR-9 Purkinje neuron responsiveness to Sprague-Dawley and GEPR-NE under these conditions revealed some intriguing differences. Concentration-response curves for GEPR-9 neurons displayed a 3-fold rightward shift of the concentration-response curves for both GABA and muscimol (Figs. 1A and 2A) with no alteration in maximal response. In contrast, the concentration-response curves for GABA and muscimol in GEPR-3 neurons were characterized by a depressed maximum response (Figs. 1B and 2B) without a difference in the EC50 value (Table 3). The EC50 values for GABA and muscimol calculated for the control strains in these studies are comparable to values previously reported in the literature for Purkinje neurons (Cheun and Yeh, 1992; Itier et al., 1996). The change in sensitivity in the GEPR-9 versus the change in GABA efficacy in the GEPR-3 raises the possibility that the molecular basis underlying the change in GABA responsiveness may differ between the two strains. Just as in GEPR-9 neurons, the GEPR-3 neurons exhibit normal responsiveness to the excitatory agonists glutamate and aspartate, indicating a specific change in responsiveness to GABA. These data further reinforce the conclusion that a selective abnormality of GABAergic neurotransmission exists in the GEPR animals and now extends that idea to question whether different changes in this molecular entity may account for the difference in seizure pattern observed in the two strains.

We also examined the effects of two modulators of the action of GABA on Purkinje neurons, diazepam (an allosteric modulator) and norepinephrine, a biogenic amine thought to modulate the action of GABA via presynaptic mechanisms (Mitoma and Konishi, 1999). The response to concentrations of GABA near the EC50 value for each animal strain was compared with responses in the presence of either norepinephrine or diazepam (Table 4). Although it was hypothesized that differences might exist for the modulatory actions of these compounds, no such differences were found. The relatively weak hyperpolarizing effect of diazepam is also consistent with the idea that there is relatively low endogenous GABAergic activity in the slices as suggested by the lack of effect of bicuculline. These studies are the first to quantitatively investigate the interaction between GABA and the allosteric modulator diazepam in the GEPR-9, and suggest that the alteration in the GABAA receptor characteristics that occurs in the GEPR-9 strain does not involve those subunits that serve as the ligand binding site for the benzodiazepines.

In conclusion, the present studies demonstrate a specific 3-fold decrease in the sensitivity of Purkinje neurons in GEPR-9 animals to GABAA receptor activation. The results also suggest that the underlying cause of this reduced sensitivity could be either a reduction in receptor number/density or an alteration in the chloride channel properties. However, radioligand binding studies have revealed either an increase (Booker et al., 1986) or no change (Gould et al., 1995) in receptor properties in the GEPR-9 cerebral and cerebellar cortex. In addition, the absence of a difference in the action of diazepam either alone or as an allosteric modulator of GABA action is consistent with the binding data of Gould et al. (1995) who found no significant difference in the number of [3H]muscimol or [3H]flunitrazepam binding sites in the GEPR-9. Thus, it is likely that a decrease in chloride channel gating is responsible for the GABA subsensitivity in the GEPR-9.

In contrast to the GEPR-9 animals, the specific decrease in responsiveness of the GEPR-3 animals to GABAA receptor activation is characterized by a depression of the maximum without an alteration in EC50 value. A decrease in receptor affinity would cause an increase in EC50 value without a change in maximum response. A decrease in the density of receptors could also depress the maximum, depending upon the receptor reserve, but would also increase the EC50 value (Ruffolo, 1982). Thus, the reduced efficacy of GABAergic neurotransmission in the GEPR-3 is likely to reside in either the single chloride channel characteristics or the macroscopic chloride currents rather than in the GABA receptor-binding site per se. Although it is likely that a decrease in chloride gating is also responsible for the reduced responsiveness to GABA in the GEPR-3 animals, the molecular abnormality leading to this reduced responsiveness must be different from that which accounts for the subsensitivity observed in the GEPR-9 strain. This difference in alteration of GABA responsiveness could provide a valuable target for examining the factors that contribute to the different patterns of seizure expression between the strains. Furthermore, the differences in sensitivity versus efficacy described in these studies may provide a valuable tool to explore the impact of receptor subunit composition on receptor function.

    Footnotes

Accepted for publication August 23, 2000.

Received for publication March 31, 2000.

1 This study was supported in part by National Institutes of Health Training Grant T32 GM 07039 and by funds from the Mylan Endowment.

2 Current address: Dept. of Pharmacology and Therapeutics, 100267 JHMHSC, 1600 SW Archer Rd., University of Florida, College of Medicine, Gainesville, FL 32606.

Send reprint requests to: Dr. David A. Taylor, Department of Pharmacology and Toxicology, Robert C. Byrd Health Sciences Center, P.O. Box 9223, West Virginia University School of Medicine, Morgantown, WV 26506-9223. E-mail: dtaylor{at}hsc.wvu.edu

    Abbreviations

GEPR, genetically epilepsy-prone rat; GEPR-9, severe genetically epilepsy-prone rat; GEPR-3, moderately severe genetically epilepsy-prone rat; GEPR-NE, genetic control; GABA, gamma -aminobutyric acid; aCSF, artificial cerebrospinal fluid; RMP, resting membrane potential; IR, input resistance.

    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References


0022-3565/00/2953-1258$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. E. Calcagnotto, M. F. Paredes, and S. C. Baraban
Heterotopic Neurons with Altered Inhibitory Synaptic Function in an Animal Model of Malformation-Associated Epilepsy
J. Neurosci., September 1, 2002; 22(17): 7596 - 7605.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molnar, L. R.
Right arrow Articles by Taylor, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molnar, L. R.
Right arrow Articles by Taylor, D. A.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition